82_FR_56268 82 FR 56042 - Meeting of the Chronic Fatigue Syndrome Advisory Committee

82 FR 56042 - Meeting of the Chronic Fatigue Syndrome Advisory Committee

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Federal Register Volume 82, Issue 226 (November 27, 2017)

Page Range56042-56042
FR Document2017-25550

As stipulated by the Federal Advisory Committee Act, the U.S. Department of Health and Human Services (HHS) is hereby giving notice that a meeting of the Chronic Fatigue Syndrome Advisory Committee (CFSAC) will take place and will be open to the public.

Federal Register, Volume 82 Issue 226 (Monday, November 27, 2017) 
[Federal Register Volume 82, Number 226 (Monday, November 27, 2017)]
[Notices]
[Page 56042]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-25550]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the Chronic Fatigue Syndrome Advisory Committee

AGENCY: Office of the Assistant Secretary for Health, Office of the 
Secretary, Department of Health and Human Services.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the U.S. 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting of the Chronic Fatigue Syndrome Advisory Committee 
(CFSAC) will take place and will be open to the public.

DATES: The CFSAC in person meeting will be held on Wednesday, December 
13, 2017, from 9:00 a.m. until 3:30 p.m. and Thursday, December 14, 
2017, from 9:00 a.m. until 5:00 p.m. (EST).

ADDRESSES: U.S. Department of Health and Human Services, Hubert H. 
Humphrey Building, Room 800, 200 Independence Avenue SW., Washington, 
DC 20201.

FOR FURTHER INFORMATION CONTACT: Commander Gustavo Ceinos, MPH, 
Designated Federal Officer, Chronic Fatigue Syndrome Advisory 
Committee, Department of Health and Human Services, 200 Independence 
Avenue SW., Room 728F6, Washington, DC 20201. Please direct all 
inquiries to [email protected] or 202-690-7650.

SUPPLEMENTARY INFORMATION: The CFSAC is authorized under 42 U.S.C. 
217a, Section 222 of the Public Health Service Act, as amended. The 
purpose of the CFSAC is to provide advice and recommendations to the 
Secretary of Health and Human Services, through the Assistant Secretary 
for Health (ASH), on issues related to myalgic encephalomyelitis/
chronic fatigue syndrome (ME/CFS). The issues can include factors 
affecting access and care for persons with ME/CFS; the science and 
definition of ME/CFS; and broader public health, clinical, research, 
and educational issues related to ME/CFS.
    The agenda for this meeting, call-in information and location will 
be posted on the CFSAC Web site http://www.hhs.gov/ash/advisory-committees/cfsac/meetings/index.html.
    Request to speak to the committee: Each day of the meeting an hour 
has been scheduled for public comments via telephone or in person. 
Individuals will have three minutes to present their comments. Priority 
will be given to individuals who have not provided public comment 
within the previous twelve months. We are unable to place international 
calls for public comments. To request a time slot for public comments, 
please send an email to [email protected] by close of business on Monday, 
November 27, 2017. The email should contain the speaker's name and the 
phone number that will be used for public comments.
    An email from the CFSAC Support Team will be sent back to you 
confirming receipt of your request. If the email confirmation is not 
received within two working days, please call 202-690-7650.
    Request to provide written comments: Individuals who would like to 
provide only written testimony to the Committee members and do not wish 
to speak, should indicate so in their email when submitting their 
written testimony. It is preferred, but not required, that the 
submitted testimony be prepared in digital format and typed using a 12-
pitch font. Written comments must not exceed 5 single-space pages, and 
it is preferred, but not required that the document be prepared in the 
MS Word format. Please note that PDF files, handwritten notes, charts, 
and photographs cannot be accepted. Materials submitted should not 
include sensitive personal information, such as social security number, 
birthdates, driver's license number, passport number, financial account 
number, or credit or debit card number. If you wish to remain anonymous 
please specify this in your email, otherwise your name will be included 
at the top of your written comments.
    The Committee welcomes input on any topic related to ME/CFS.

     Dated: November 17, 2017.
Gustavo Ceinos,
CDR, USPHS, Designated Federal Officer, Chronic Fatigue Syndrome 
Advisory Committee.
[FR Doc. 2017-25550 Filed 11-24-17; 8:45 am]
 BILLING CODE 4150-42-P

56042 Federal Register / Vol. 82, No. 226 / Monday, November 27, 2017 / Notices HRSA specifically requests comments syndrome (ME/CFS). The issues can Dated: November 17, 2017. on (1) the necessity and utility of the include factors affecting access and care Gustavo Ceinos, proposed information collection for the for persons with ME/CFS; the science CDR, USPHS, Designated Federal Officer, proper performance of the agency’s and definition of ME/CFS; and broader Chronic Fatigue Syndrome Advisory functions, (2) the accuracy of the public health, clinical, research, and Committee. estimated burden, (3) ways to enhance educational issues related to ME/CFS. [FR Doc. 2017–25550 Filed 11–24–17; 8:45 am] the quality, utility, and clarity of the BILLING CODE 4150–42–P The agenda for this meeting, call-in information to be collected, and (4) the use of automated collection techniques information and location will be posted or other forms of information on the CFSAC Web site http:// DEPARTMENT OF HEALTH AND technology to minimize the information www.hhs.gov/ash/advisory-committees/ HUMAN SERVICES collection burden. cfsac/meetings/index.html. Request to speak to the committee: Office of the Secretary Amy McNulty, Each day of the meeting an hour has Findings of Research Misconduct Acting Director, Division of the Executive Secretariat. been scheduled for public comments via telephone or in person. Individuals will AGENCY: Office of the Secretary, HHS. [FR Doc. 2017–25507 Filed 11–24–17; 8:45 am] have three minutes to present their ACTION: Notice. BILLING CODE 4165–15–P comments. Priority will be given to Notice is hereby given that the Office individuals who have not provided of Research Integrity (ORI) has taken DEPARTMENT OF HEALTH AND public comment within the previous final action in the following case: HUMAN SERVICES twelve months. We are unable to place Mahandranauth Chetram, Ph.D., international calls for public comments. Georgetown University and Emory Meeting of the Chronic Fatigue To request a time slot for public School of Medicine: Based on the report Syndrome Advisory Committee comments, please send an email to of an investigation conducted by AGENCY: Office of the Assistant cfsac@hhs.gov by close of business on Georgetown University (GU), Secretary for Health, Office of the Monday, November 27, 2017. The email Respondent’s admission at Emory Secretary, Department of Health and should contain the speaker’s name and School of Medicine (ESOM), and Human Services. the phone number that will be used for additional analysis conducted by ORI in public comments. its oversight review, ORI found that Dr. ACTION: Notice. Mahandranauth Chetram, former An email from the CFSAC Support SUMMARY: As stipulated by the Federal postdoctoral fellow, Department of Team will be sent back to you Oncology, GU, and former postdoctoral Advisory Committee Act, the U.S. confirming receipt of your request. If the Department of Health and Human fellow, Department of Pediatrics, ESOM, email confirmation is not received engaged in research misconduct in Services (HHS) is hereby giving notice within two working days, please call research supported by National Cancer that a meeting of the Chronic Fatigue 202–690–7650. Institute (NCI), National Institutes of Syndrome Advisory Committee (CFSAC) will take place and will be Request to provide written comments: Health (NIH), grants R01 CA113447, R01 open to the public. Individuals who would like to provide CA092306, and T32 CA09686 while at DATES: The CFSAC in person meeting only written testimony to the Committee GU, and National Institute of Diabetes will be held on Wednesday, December members and do not wish to speak, and Digestive and Kidney Diseases 13, 2017, from 9:00 a.m. until 3:30 p.m. should indicate so in their email when (NIDDK), NIH, grant R01 DK059380 and Thursday, December 14, 2017, from submitting their written testimony. It is while at ESOM. ORI found that Respondent engaged 9:00 a.m. until 5:00 p.m. (EST). preferred, but not required, that the in research misconduct at GU by ADDRESSES: U.S. Department of Health submitted testimony be prepared in falsifying Western blot images and and Human Services, Hubert H. digital format and typed using a 12- polymerase chain reaction (PCR) data Humphrey Building, Room 800, 200 pitch font. Written comments must not included in an unfunded grant Independence Avenue SW., exceed 5 single-space pages, and it is application, R01 CA193344–01A1, and Washington, DC 20201. preferred, but not required that the in a manuscript submitted to Cancer FOR FURTHER INFORMATION CONTACT: document be prepared in the MS Word Cell (‘‘The DNA Repair Protein, NTHL1 Commander Gustavo Ceinos, MPH, format. Please note that PDF files, Functions as an Oncoprotein by Designated Federal Officer, Chronic handwritten notes, charts, and Activating the Canoncial Wnt Pathway.’’ Fatigue Syndrome Advisory Committee, photographs cannot be accepted. Submitted to Cancer Cell; hereafter Department of Health and Human Materials submitted should not include referred to as the ‘‘Cancer Cell Services, 200 Independence Avenue sensitive personal information, such as manuscript’’). Subsequently, after SW., Room 728F6, Washington, DC social security number, birthdates, Respondent was aware of the research 20201. Please direct all inquiries to driver’s license number, passport misconduct findings from GU, cfsac@hhs.gov or 202–690–7650. number, financial account number, or Respondent engaged in research SUPPLEMENTARY INFORMATION: The credit or debit card number. If you wish misconduct at ESOM and falsified RT– asabaliauskas on DSKBBXCHB2PROD with NOTICES CFSAC is authorized under 42 U.S.C. to remain anonymous please specify PCR data on Excel spreadsheets in the 217a, Section 222 of the Public Health this in your email, otherwise your name research record and in a figure Service Act, as amended. The purpose will be included at the top of your generated from the false data included of the CFSAC is to provide advice and written comments. in a manuscript submitted to and recommendations to the Secretary of withdrawn from Scientific Reports Health and Human Services, through The Committee welcomes input on (‘‘Immipramine Blue Sensitively and the Assistant Secretary for Health any topic related to ME/CFS. Selectively Targets FLT3–ITD Positive (ASH), on issues related to myalgic Acute Myeloid Leukemia Cells.’’ encephalomyelitis/chronic fatigue Scientific Reports 7(1):4447, 2017 June VerDate Sep<11>2014 16:59 Nov 24, 2017 Jkt 244001 PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1


Document Created: 2017-11-25 01:08:59
Document Modified: 2017-11-25 01:08:59
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
ActionNotice.
DatesThe CFSAC in person meeting will be held on Wednesday, December 13, 2017, from 9:00 a.m. until 3:30 p.m. and Thursday, December 14, 2017, from 9:00 a.m. until 5:00 p.m. (EST).
ContactCommander Gustavo Ceinos, MPH, Designated Federal Officer, Chronic Fatigue Syndrome Advisory Committee, Department of Health and Human Services, 200 Independence Avenue SW., Room 728F6, Washington, DC 20201. Please direct all inquiries to [email protected] or 202-690-7650.
FR Citation82 FR 56042 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR